Genotypic resistance in HIV-Infected naive patients receiving abacavir plus lamivudine and efavirenz

被引：1
|
作者：
Ferrer, Elena [1 ]
Niubo, Jordi
Crespo, Manuel
Gatell, Josep Maria
Sanz, Jose
Veloso, Sergio
Llibre, Josep Maria
Barrufet, Pilar
Sanchez, Pochita
Podzamczer, Daniel
机构：
[1] Hosp Univ Bellvitge, Barcelona, Spain
[2] Hosp Gen Valle Hebron, Barcelona, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Principe Asturias, Alcala De Henares, Spain
[5] Hosp Joan 23, Tarragona, Spain
[6] Hosp Calella, Barcelona, Spain
[7] Hosp Mataro, Barcelona, Spain
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2007年 / 46卷 / 02期
关键词：
D O I：
10.1097/QAI.0b013e318074efd1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：253 / 255
页数：3
相关论文
共 50 条
  • [1] Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naive HIV-infected adults
    Ruane, PJ
    Parenti, DM
    Margolis, DM
    Shepp, DH
    Babinchak, TJ
    van Kempen, AS
    Kauf, TL
    Danehower, SA
    Yau, L
    Hessenthaler, SM
    Goodwin, SD
    Hernandez, JE
    HIV CLINICAL TRIALS, 2003, 4 (04): : 231 - 243
  • [2] Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults
    DeJesus, E
    Herrera, G
    Teofilo, E
    Gerstoft, J
    Buendia, CB
    Brand, JD
    Brothers, CH
    Hernandez, J
    Castillo, SA
    Bonny, T
    Lanier, ER
    Scott, TR
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 1038 - 1046
  • [3] Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
    Calza, Leonardo
    Magistrelli, Eleonora
    Danese, Ilaria
    Colangeli, Vincenzo
    Borderi, Marco
    Bon, Isabella
    Re, Maria Carla
    Mancini, Rita
    Conti, Matteo
    Motta, Roberto
    Viale, Pierluigi
    CURRENT HIV RESEARCH, 2016, 14 (01) : 61 - 70
  • [4] Genotypic resistance profile in treatment-experienced HIV-infected individuals after abacavir and efavirenz salvage regimen
    Vallejo, A
    Olivera, M
    Rubio, A
    Sánchez-Quijano, A
    Lissen, E
    Leal, M
    ANTIVIRAL RESEARCH, 2004, 61 (02) : 129 - 132
  • [5] Induction with abacavir/lamivudine/zidovudine plus efavirenz for 48 weeks followed by 48-week maintenance with abacavir/lamivudine/zidovudine alone in antiretroviral-naive HIV-1-infected patients
    Markowitz, M
    Hill-Zabala, C
    Lang, J
    DeJesus, E
    Liao, QM
    Lanier, ER
    Davis, EA
    Shaefer, M
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) : 257 - 264
  • [6] Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study)
    Allavena, C.
    Volteau, C.
    Andre-Garnier, E.
    Guimard, T.
    Hall, N.
    Ithatchatourian, L.
    Morrier, M.
    Billaud, E.
    Rodallec, A.
    Reliquet, V.
    Jovelin, T.
    Le Guen, L.
    Perre, P.
    Gregoire, M.
    Raffi, F.
    MEDECINE ET MALADIES INFECTIEUSES, 2019, 49 (07): : 505 - 510
  • [7] Comparison of Abacavir/Lamivudine and Tenofovir/Emtricitabine Among Treatment-Naive HIV-Infected Patients Initiating Therapy
    Tan, Darrell H. S.
    Chan, Keith
    Raboud, Janet
    Cooper, Curtis
    Montaner, Julio S. G.
    Walmsley, Sharon
    Hogg, Robert S.
    Klein, Marina B.
    Machouf, Nima
    Rourke, Sean B.
    Tsoukas, Chris
    Loutfy, Mona R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (01) : 38 - 46
  • [8] EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ON PLATELET ACTIVATING FACTOR METABOLISM IN NAIVE HIV-INFECTED PATIENTS: II) STUDY OF THE ABACAVIR/LAMIVUDINE/EFAVIRENZ HAART REGIMEN
    Chini, M.
    Tsoupras, A. B.
    Mangafas, N.
    Tsogas, N.
    Papakonstantinou, V. D.
    Fragopoulou, E.
    Antonopoulou, S.
    Gargalianos, P.
    Demopoulos, C. A.
    Lazanasi, M. C.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (01) : 247 - 258
  • [9] Zidovudine/lamivudine/abacavir plus tenofovir in HIV-Infected naive patients: A 96-week prospective one-arm pilot study
    Ferrer, Elena
    Gatell, Jose Maria
    Sanchez, Pochita
    Domingo, Pere
    Puig, Teresa
    Niubo, Jordi
    Cortes, Cristina
    Veloso, Sergio
    Pedrol, Enric
    Leon, Agathe
    Gutierrez, Mar
    Podzamczer, Daniel
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (07) : 931 - 934
  • [10] Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects
    Gallant, JE
    Rodriguez, AE
    Weinberg, WG
    Young, B
    Berger, DS
    Lim, ML
    Liao, QM
    Ross, L
    Johnson, J
    Shaefer, MS
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (11): : 1921 - 1930
12345